welcome Welcome

“May all be happy, may all be healed, may all be at peace and may no one ever suffer."


Loading...
Malignant gastrointestinal stromal tumors Generics
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
...
Imatinib Mesylate
Chemotherapy & Immunosuppressants
...
Raloxifene Hydrochloride
N/A

Malignant gastrointestinal stromal tumors - Generics

Malignant gastrointestinal stromal tumors (GISTs) are rare and aggressive tumors that develop in the gastrointestinal tract, usually in the stomach or small intestine. GISTs are a type of soft tissue sarcoma and are often difficult to diagnose due to their rarity and variability in presentation.

Symptoms of Malignant Gastrointestinal Stromal Tumors:

  • Abdominal pain or discomfort
  • Nausea and vomiting
  • Gastrointestinal bleeding
  • Anemia
  • Fatigue
  • Weight loss

Diagnosis of Malignant Gastrointestinal Stromal Tumors:

  • Imaging tests such as CT scans, MRI, or ultrasound may be used to detect the presence of tumors.
  • Biopsies may also be performed to confirm the diagnosis and determine the specific type of GIST.

Treatment of Malignant Gastrointestinal Stromal Tumors:

  • Surgery is the main treatment for GISTs. The goal of surgery is to remove the tumor and any surrounding tissue that may be affected.
  • Targeted therapies, such as imatinib, may be used in combination with surgery to treat GISTs. These drugs target specific proteins that are overexpressed in GIST cells.
  • Chemotherapy and radiation therapy are generally not effective for treating GISTs.

Prognosis of Malignant Gastrointestinal Stromal Tumors:

  • The prognosis for GISTs depends on several factors, including the size and location of the tumor, the degree of malignancy, and the patient's overall health.
  • Tumors that are smaller, located in the stomach, and have not spread to other organs have a better prognosis.
  • The 5-year survival rate for patients with malignant GISTs is approximately 50-60%.

In conclusion, malignant gastrointestinal stromal tumors are rare and aggressive tumors that develop in the gastrointestinal tract. Diagnosis is often difficult, and treatment typically involves surgery and targeted therapies. Prognosis depends on several factors and can vary widely. If you suspect that you may have GISTs or are experiencing symptoms, it is recommended that you consult a healthcare professional for diagnosis and treatment options.


Germs disease
Bacterial ear infections
Germs disease
Dental disease
Dental pain
Dental disease
Skin disease
Dermatitis
Skin disease
Tumor disease
Tumor lysis syndrome
Tumor disease
Hypertension
Pre-or post-operative sed...
Hypertension
Cancer
Essential thrombocythemia
Cancer
Bladder disease
Non-gonococcal urethritis
Bladder disease
Renal disease
Renal impairment
Renal disease

Searching Keywords Idea
Malignant gastrointestinal stromal tumors, মারাত্মক গ্যাস্ট্রোইনটেস্টাইনাল স্ট্রোমাল টিউমার

Bangladesh is Number One in Digital Medical Management.
To be happy, beautiful, healthy, wealthy, hale and long-lived stay with DM3S.